PROSPECTS FOR NEW DRUG-TREATMENT IN IDIOPATHIC PARKINSONISM

Parkinson's disease is one of the most common neurological disorders o f the elderly. However, several recent drug developments have been mad e in the treatment of idiopathic parkinsonism (IF). The authors descri be the most promising new drugs for treatment of the motor symptoms of IF, briefly discuss two promising monoamine oxidase inhibitors and re view the newer medications for the treatment of the psychiatric sympto ms associated with IP. They also survey some of the future therapeutic options in early stages of development.